Journal of Clinical Oncology , 0732-183X

Journal

1 - 10 out of 120Page size: 10

Publications

  1. Published

    Early mortality after diagnosis of multiple myeloma: Analysis of patients endered onto the United Kingdom Medical Research Council trials between 1980 and 2002

    Gulnaz Begum, Janet Dunn & Mark Drayson, 28 Nov 2005, In: Journal of Clinical Oncology. 23, p. 9219-9226 8 p.

    Research output: Contribution to journal › Article

  2. Published

    Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion

    Judy Powell, Malcolm Taylor, Paul Moss & Tatjana Stankovic, 1 Dec 2007, In: Journal of Clinical Oncology. 25, 34, p. 5448-57 10 p.

    Research output: Contribution to journal › Article

  3. Published

    Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial.

    Toon Brookes, Lucinda Billingham & Daniel Rea, 21 Mar 2011, In: Journal of Clinical Oncology. 29, 12, p. 1531-1538

    Research output: Contribution to journal › Article

  4. Published

    Mammostrat as an immunohistochemical multigene assay for prediction of early relapse risk in the tamoxifen versus exemestane adjuvant multicenter trial pathology study

    Daniel Rea, 20 Dec 2012, In: Journal of Clinical Oncology . 30, 36, p. 4477-84 8 p.

    Research output: Contribution to journal › Article › peer-review

  5. Published

    Trans-aTTom: Breast Cancer Index for prediction of endocrine benefit and late distant recurrence (DR) in patients with HR+ breast cancer treated in the adjuvant tamoxifen—To offer more? (aTTom) trial.

    Ikhlaaq Ahmed, Sarah Pirrie & Daniel Rea, 20 May 2019, In: Journal of Clinical Oncology. 37, 15_suppl, p. 505 1 p.

    Research output: Contribution to journal › Abstract › peer-review

  6. Published

    Quantification of Hormone Receptors to Guide Adjuvant Therapy Choice in Early Breast Cancer: Better Methods Required for Improved Utility

    Daniel Rea, 1 Sep 2011, In: Journal of Clinical Oncology. 29, 27, p. 3715-3716 2 p.

    Research output: Contribution to journal › Article

  7. Published

    Predicting anthracycline benefit: TOP2A and CEP17 - Not only but also

    Daniel Rea, 20 May 2015, In: Journal of Clinical Oncology. 33, 15, p. 1680-1687 8 p.

    Research output: Contribution to journal › Article › peer-review

  8. Published

    Collaborative Research in Childhood Cancer Survivorship: The Current Landscape

    Michael Hawkins, 20 Sep 2015, In: Journal of Clinical Oncology . 33, 27, p. 3055-64 10 p.

    Research output: Contribution to journal › Article › peer-review

  9. Published

    Results of POUT: A phase III randomised trial of perioperative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC)

    9 Feb 2018, In: Journal of Clinical Oncology . 36, Suppl 6S, Abstract 407.

    Research output: Contribution to journal › Abstract › peer-review

  10. Published

    Marimastat as first line therapy for patients with unresectable pancreatic cancer - A randomised trial

    Simon Bramhall, 1 Jan 2001, In: Journal of Clinical Oncology. 19, 15, p. 3447-3455 9 p.

    Research output: Contribution to journal › Article

Previous 1 2 3 4 5 6 7 8 ...12 Next